Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study.
Pfeifer A, Knigge U, Mortensen J, Oturai P, Berthelsen AK, Loft A, Binderup T, Rasmussen P, Elema D, Klausen TL, Holm S, von Benzon E, Højgaard L, Kjaer A. Pfeifer A, et al. Among authors: berthelsen ak. J Nucl Med. 2012 Aug;53(8):1207-15. doi: 10.2967/jnumed.111.101469. Epub 2012 Jul 10. J Nucl Med. 2012. PMID: 22782315 Free article. Clinical Trial.
(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2.
Olsen IH, Langer SW, Federspiel BH, Oxbøl J, Loft A, Berthelsen AK, Mortensen J, Oturai P, Knigge U, Kjær A. Olsen IH, et al. Among authors: berthelsen ak. Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):59-72. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27069766 Free PMC article.
Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging.
Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A. Skovgaard D, et al. Among authors: berthelsen ak. J Nucl Med. 2017 Mar;58(3):379-386. doi: 10.2967/jnumed.116.178970. Epub 2016 Sep 8. J Nucl Med. 2017. PMID: 27609788 Free article.
18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial.
Christensen TN, Langer SW, Persson G, Larsen KR, Loft A, Amtoft AG, Berthelsen AK, Johannesen HH, Keller SH, Kjaer A, Fischer BM. Christensen TN, et al. Among authors: berthelsen ak. J Nucl Med. 2021 May 10;62(5):628-635. doi: 10.2967/jnumed.120.247742. Epub 2020 Oct 9. J Nucl Med. 2021. PMID: 33037090 Free PMC article. Clinical Trial.
18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study.
Binderup T, Knigge U, Johnbeck CB, Loft A, Berthelsen AK, Oturai P, Mortensen J, Federspiel B, Langer SW, Kjaer A. Binderup T, et al. Among authors: berthelsen ak. J Nucl Med. 2021 Jun 1;62(6):808-815. doi: 10.2967/jnumed.120.244798. Epub 2020 Oct 16. J Nucl Med. 2021. PMID: 33067340 Free PMC article.
PET/MRI in cancer patients: first experiences and vision from Copenhagen.
Kjær A, Loft A, Law I, Berthelsen AK, Borgwardt L, Löfgren J, Johnbeck CB, Hansen AE, Keller S, Holm S, Højgaard L. Kjær A, et al. Among authors: berthelsen ak. MAGMA. 2013 Feb;26(1):37-47. doi: 10.1007/s10334-012-0357-0. Epub 2012 Dec 25. MAGMA. 2013. PMID: 23266511
102 results